Commonwealth Equity Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.2M Sell
11,308
-2,899
-20% -$308K ﹤0.01% 2415
2025
Q1
$1.76M Buy
14,207
+1,323
+10% +$164K ﹤0.01% 1998
2024
Q4
$1.59M Sell
12,884
-784
-6% -$96.6K ﹤0.01% 2036
2024
Q3
$1.52M Buy
13,668
+146
+1% +$16.3K ﹤0.01% 2022
2024
Q2
$1.44M Buy
13,522
+364
+3% +$38.8K ﹤0.01% 2005
2024
Q1
$1.59M Buy
13,158
+2,318
+21% +$279K ﹤0.01% 1927
2023
Q4
$1.33M Buy
10,840
+767
+8% +$94.3K ﹤0.01% 1969
2023
Q3
$1.3M Buy
10,073
+962
+11% +$125K ﹤0.01% 1891
2023
Q2
$1.13M Buy
9,111
+47
+0.5% +$5.82K ﹤0.01% 2008
2023
Q1
$1.33K Sell
9,064
-300
-3% -$44 ﹤0.01% 1847
2022
Q4
$1.49M Sell
9,364
-96
-1% -$15.3K ﹤0.01% 1688
2022
Q3
$1.26M Sell
9,460
-30
-0.3% -$4K ﹤0.01% 1740
2022
Q2
$1.48M Sell
9,490
-677
-7% -$106K ﹤0.01% 1608
2022
Q1
$1.58M Buy
10,167
+447
+5% +$69.6K ﹤0.01% 1647
2021
Q4
$1.24M Sell
9,720
-10,475
-52% -$1.33M ﹤0.01% 1832
2021
Q3
$2.63M Buy
20,195
+8,672
+75% +$1.13M 0.01% 1265
2021
Q2
$2.05M Buy
11,523
+7,397
+179% +$1.31M 0.01% 1407
2021
Q1
$678K Sell
4,126
-10,523
-72% -$1.73M ﹤0.01% 2082
2020
Q4
$2.42M Buy
14,649
+11,559
+374% +$1.91M 0.01% 1118
2020
Q3
$440K Sell
3,090
-354
-10% -$50.4K ﹤0.01% 2058
2020
Q2
$380K Sell
3,444
-920
-21% -$102K ﹤0.01% 2091
2020
Q1
$435K Buy
4,364
+437
+11% +$43.6K ﹤0.01% 1789
2019
Q4
$586K Buy
3,927
+816
+26% +$122K ﹤0.01% 1782
2019
Q3
$398K Sell
3,111
-227
-7% -$29K ﹤0.01% 2001
2019
Q2
$475K Buy
3,338
+92
+3% +$13.1K ﹤0.01% 1842
2019
Q1
$464K Buy
3,246
+290
+10% +$41.5K ﹤0.01% 1800
2018
Q4
$366K Sell
2,956
-244
-8% -$30.2K ﹤0.01% 1868
2018
Q3
$538K Sell
3,200
-309
-9% -$52K ﹤0.01% 1749
2018
Q2
$605K Buy
3,509
+226
+7% +$39K ﹤0.01% 1618
2018
Q1
$495K Sell
3,283
-113
-3% -$17K ﹤0.01% 1720
2017
Q4
$457K Sell
3,396
-723
-18% -$97.3K ﹤0.01% 1752
2017
Q3
$602K Sell
4,119
-25
-0.6% -$3.65K ﹤0.01% 1494
2017
Q2
$644K Sell
4,144
-1,500
-27% -$233K ﹤0.01% 1402
2017
Q1
$819K Sell
5,644
-662
-10% -$96.1K 0.01% 1223
2016
Q4
$688K Buy
6,306
+358
+6% +$39.1K 0.01% 1231
2016
Q3
$723K Buy
5,948
+267
+5% +$32.5K 0.01% 1167
2016
Q2
$803K Buy
5,681
+230
+4% +$32.5K 0.01% 1094
2016
Q1
$712K Sell
5,451
-92
-2% -$12K 0.01% 1122
2015
Q4
$779K Buy
5,543
+330
+6% +$46.4K 0.01% 1057
2015
Q3
$692K Buy
5,213
+712
+16% +$94.5K 0.01% 1074
2015
Q2
$792K Sell
4,501
-120
-3% -$21.1K 0.01% 1084
2015
Q1
$798K Sell
4,621
-279
-6% -$48.2K 0.01% 1071
2014
Q4
$802K Buy
4,900
+686
+16% +$112K 0.01% 1012
2014
Q3
$677K Buy
4,214
+770
+22% +$124K 0.01% 1064
2014
Q2
$506K Sell
3,444
-1,405
-29% -$206K 0.01% 1235
2014
Q1
$672K Sell
4,849
-2,282
-32% -$316K 0.01% 1026
2013
Q4
$902K Sell
7,131
-207
-3% -$26.2K 0.01% 822
2013
Q3
$675K Buy
7,338
+190
+3% +$17.5K 0.01% 924
2013
Q2
$491K Buy
+7,148
New +$491K 0.01% 1031